R01 CA120956/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2008	5
2009	2
2010	7
2011	4
2012	6
2013	9
2014	5
2015	7
2016	6
2024	0

1

Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells.

Hurton LV, Singh H, Najjar AM, Switzer KC, Mi T, Maiti S, Olivares S, Rabinovich B, Huls H, Forget MA, Datar V, Kebriaei P, Lee DA, Champlin RE, Cooper LJ. Hurton LV, et al. Proc Natl Acad Sci U S A. 2016 Nov 29;113(48):E7788-E7797. doi: 10.1073/pnas.1610544113. Epub 2016 Nov 14. Proc Natl Acad Sci U S A. 2016. PMID: 27849617 Free PMC article.

2

Test-driving CARs.

Cooper LJ. Cooper LJ. Blood. 2008 Sep 15;112(6):2172-3. doi: 10.1182/blood-2008-06-163006. Blood. 2008. PMID: 18779394 Free article. No abstract available.

3

Clinical applications of gamma delta T cells with multivalent immunity.

Deniger DC, Moyes JS, Cooper LJ. Deniger DC, et al. Front Immunol. 2014 Dec 11;5:636. doi: 10.3389/fimmu.2014.00636. eCollection 2014. Front Immunol. 2014. PMID: 25566249 Free PMC article. Review.

4

A transposon and transposase system for human application.

Hackett PB, Largaespada DA, Cooper LJ. Hackett PB, et al. Mol Ther. 2010 Apr;18(4):674-83. doi: 10.1038/mt.2010.2. Epub 2010 Jan 26. Mol Ther. 2010. PMID: 20104209 Free PMC article. Review.

5

Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor.

Jena B, Dotti G, Cooper LJ. Jena B, et al. Blood. 2010 Aug 19;116(7):1035-44. doi: 10.1182/blood-2010-01-043737. Epub 2010 May 3. Blood. 2010. PMID: 20439624 Free PMC article. Review.

6

Immunotherapy targeting EBV-expressing lymphoproliferative diseases.

Bollard CM, Cooper LJ, Heslop HE. Bollard CM, et al. Best Pract Res Clin Haematol. 2008 Sep;21(3):405-20. doi: 10.1016/j.beha.2008.06.002. Best Pract Res Clin Haematol. 2008. PMID: 18790446 Free PMC article. Review.

7

CARs in chronic lymphocytic leukemia -- ready to drive.

Hosing C, Kebriaei P, Wierda W, Jena B, Cooper LJN, Shpall E. Hosing C, et al. Curr Hematol Malig Rep. 2013 Mar;8(1):60-70. doi: 10.1007/s11899-012-0145-y. Curr Hematol Malig Rep. 2013. PMID: 23225251 Free PMC article. Review.

8

Manufacture of T cells using the Sleeping Beauty system to enforce expression of a CD19-specific chimeric antigen receptor.

Singh H, Moyes JS, Huls MH, Cooper LJ. Singh H, et al. Cancer Gene Ther. 2015 Mar;22(2):95-100. doi: 10.1038/cgt.2014.69. Epub 2015 Jan 16. Cancer Gene Ther. 2015. PMID: 25591810 Review.

9

Translating Sleeping Beauty transposition into cellular therapies: victories and challenges.

Izsvák Z, Hackett PB, Cooper LJ, Ivics Z. Izsvák Z, et al. Bioessays. 2010 Sep;32(9):756-67. doi: 10.1002/bies.201000027. Bioessays. 2010. PMID: 20652893 Free PMC article. Review.

10

Evaluating risks of insertional mutagenesis by DNA transposons in gene therapy.

Hackett PB, Largaespada DA, Switzer KC, Cooper LJ. Hackett PB, et al. Transl Res. 2013 Apr;161(4):265-83. doi: 10.1016/j.trsl.2012.12.005. Epub 2013 Jan 10. Transl Res. 2013. PMID: 23313630 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

50 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year